Australian Prescriber

Endometriosis and adenomyosis are common chronic conditions with diverse symptoms that can impair quality of life. Australian guidelines now support clinical diagnosis and early management in primary care without surgical confirmation.

Cardiac amyloidosis is an under-recognised but treatable cause of heart failure, particularly in older adults. Early recognition of its clinical features can facilitate timely investigation and referral for treatment with disease-modifying therapies. This article reviews provides a practical approach to recognition, investigation and referral.

Glaucoma is a leading cause of irreversible vision loss. Early diagnosis and treatment can prevent blindness. This article provides an update on screening, treatment and when to refer to an optometrist or ophthalmologist.

Advances in multiple myeloma treatment have improved survival and quality of life. It is increasingly regarded as a chronic disease, with many patients now receiving long-term therapy. Primary care clinicians play an important role in identifying and managing treatment-related adverse effects, as well as infection prevention and surveillance.

Acute moderate-to-severe hyperkalaemia is a medical emergency. This article provides a practical overview of the management of acute hyperkalaemia, including treatment rationale, latest evidence and practical considerations.

On 1 October 2026, eligibility for free COVID-19 vaccines changed when the National COVID-19 Vaccine Program (part of Australia’s emergency response to the COVID-19 pandemic) ended and COVID-19 vaccines moved to the National Immunisation Program (NIP).

Delgocitinib, a topical Janus kinase (JAK) inhibitor, provides a new treatment option for adults with chronic hand eczema who are unable to use, or have an inadequate response to, topical corticosteroids.

Vanzacaftor, tezacaftor and deutivacaftor combination therapy provides an alternative to existing therapies for people with cystic fibrosis who have a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.